These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32146163)

  • 1. Generation of mycobacterial lipoarabinomannan-specific monoclonal antibodies and their ability to identify mycobacterium isolates.
    Yan ZH; Zhao B; Pang Y; Wang XJ; Yi L; Wang HL; Yang B; Wei PJ; Jia HY; Li SP; Zhao YL; Zhang HT
    J Microbiol Immunol Infect; 2021 Jun; 54(3):437-446. PubMed ID: 32146163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
    PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
    Sigal GB; Pinter A; Lowary TL; Kawasaki M; Li A; Mathew A; Tsionsky M; Zheng RB; Plisova T; Shen K; Katsuragi K; Choudhary A; Honnen WJ; Nahid P; Denkinger CM; Broger T
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patients.
    Liu D; Gu L; Zhang R; Liu L; Shen Y; Shao Y; Wang J; Sun J; Qi T; Wang Z; Tang Y; Song W; Xun J; Lu H; Chen J
    Int J Infect Dis; 2022 May; 118():65-70. PubMed ID: 35219884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of monoclonal antibodies to identify mycobacteria grown in culture in Zimbabwe.
    Mason PR; Gwanzura L; Lowe O; Kolk AH
    Tuber Lung Dis; 1993 Jun; 74(3):195-9. PubMed ID: 8369515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.
    Hamasur B; Haile M; Pawlowski A; Schroder U; Kallenius G; Svenson SB
    Clin Exp Immunol; 2004 Oct; 138(1):30-8. PubMed ID: 15373902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of purified protein derivative mycobacterial skin test antigens in children and adolescents: purified protein derivative skin test results correlated with mycobacterial isolates.
    Margileth AM
    Pediatr Infect Dis; 1983; 2(3):225-31. PubMed ID: 6408620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of MycoDot test for the detection of anti-mycobacterial antibodies as an aid in the diagnosis of experimental Mycobacterium tuberculosis and Mycobacterium avium complex infections in mice].
    Sato K; Shimizu T; Akaki T; Tomioka H
    Kekkaku; 1998 Feb; 73(2):47-52. PubMed ID: 9545696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bispecific antibody based assay shows potential for detecting tuberculosis in resource constrained laboratory settings.
    Sarkar S; Tang XL; Das D; Spencer JS; Lowary TL; Suresh MR
    PLoS One; 2012; 7(2):e32340. PubMed ID: 22363820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sandwich antibody-based biosensor system for identification of
    Chuensirikulchai K; Laopajon W; Phunpae P; Apiratmateekul N; Surinkaew S; Tayapiwatana C; Pata S; Kasinrerk W
    J Immunoassay Immunochem; 2019; 40(6):590-604. PubMed ID: 31462139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Structural Study of Terminal Ends of Lipoarabinomannan from Mice Infected Lung Tissues and Urine of a Tuberculosis Positive Patient.
    De P; Shi L; Boot C; Ordway D; McNeil M; Chatterjee D
    ACS Infect Dis; 2020 Feb; 6(2):291-301. PubMed ID: 31762254
    [No Abstract]   [Full Text] [Related]  

  • 12. Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria--experiences from the Danish Cystic Fibrosis cohort study.
    Qvist T; Johansen IS; Pressler T; Høiby N; Andersen AB; Katzenstein TL; Bjerrum S
    BMC Infect Dis; 2014 Dec; 14():655. PubMed ID: 25471640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel phage display-derived recombinant antibodies recognizing both MPT64 native and mutant (63-bp deletion) are promising tools for tuberculosis diagnosis.
    Magalhães CG; Moreira GMSG; Ferreira MRA; Santos LMD; Finger PF; Ramos DF; Silva PEAD; Hust M; Conceição FR
    Biologicals; 2021 Jul; 72():54-57. PubMed ID: 34247914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid lateral flow test for Mycobacterium tuberculosis complex and non-tuberculous mycobacteria differentiation.
    Phunpae P; Thongkum W; Panyasit W; Laopajon W; Takheaw N; Pata S; Yasamut U; Kasinrerk W; Tayapiwatana C
    Appl Microbiol Biotechnol; 2024 Sep; 108(1):456. PubMed ID: 39222096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to lipoarabinomannan/arabinomannan - characteristics and implications for tuberculosis research and diagnostics.
    Corrigan DT; Ishida E; Chatterjee D; Lowary TL; Achkar JM
    Trends Microbiol; 2023 Jan; 31(1):22-35. PubMed ID: 35918247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Mycobacterium tuberculosis lipoarabinomannan antigen assay and rapid serology blood test for the diagnosis of bovine tuberculosis in Ethiopia.
    Zewude A; Mohammed T; Terfassa L; Hunt WG; Pan X; Balada-Llasat JM; Gebreyes W; Torrelles JB; Wang SH; Ameni G
    BMC Vet Res; 2019 Oct; 15(1):359. PubMed ID: 31640672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Rv1133c (MetE) as a marker of
    Iacobino A; Teloni R; Mancone C; Facchiano F; Di Giamberardino A; Senatore C; Di Virgilio A; Lanni A; Giannoni F; Nisini R; Mariotti S
    Front Immunol; 2024; 15():1464923. PubMed ID: 39430745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway.
    De P; Amin AG; Graham B; Martiniano SL; Caceres SM; Poch KR; Jones MC; Saavedra MT; Malcolm KC; Nick JA; Chatterjee D
    J Cyst Fibros; 2020 Sep; 19(5):801-807. PubMed ID: 32624408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real time PCR for the rapid identification and drug susceptibility of Mycobacteria present in Bronchial washings.
    Keerthirathne TP; Magana-Arachchi DN; Madegedara D; Sooriyapathirana SS
    BMC Infect Dis; 2016 Oct; 16(1):607. PubMed ID: 27782812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of monoclonal antibodies to lipoarabinomannan-B and use in the detection of mycobacterial antigens in sputum.
    Cho SN; Shin JS; Kim JD; Chong Y
    Yonsei Med J; 1990 Dec; 31(4):333-8. PubMed ID: 2127645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.